Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Ann Emerg Med. 2022 Mar 16;79(5):441–450. doi: 10.1016/j.annemergmed.2022.01.042

Table 1.

Characteristics of Buprenorphine Treatment Episodes initiated by an Emergency physician, January 1 2019–November 30, 2020

Overall % Overall N Pre-COVID Public Health Emergency N (%) Post-COVID Public Health Emergency N (%)
Total 22,846 14,456 8,390
Sex
Female 40.4 9,232 5,993 (41.8) 3,239 (38.6)
Male 59.6 13,614 8,463 (58.2) 5,151 (61.4)
Age Cohort
12–17 0.1 31 19 (0.1) 12 (0.1)
18–25 9.0 2,046 1,217 (8.4) 829 (9.9)
26–35 39.8 9,098 5,714 (39.5) 3,384 (40.3)
36–45 29.2 6,669 4,261 (29.5) 2,408 (28.7)
46–55 13.3 3,036 1,995 (13.8) 1,041 (12.4)
56–65 6.6 1,518 963 (6.7) 555 (6.6)
66+ 2.0 448 287 (2.0) 161 (1.9)
First Buprenorphine prescription payer
Medicare 5.5 1,253 820 (5.7) 433 (5.2)
Medicaid 44.5 10,167 6,240 (43.2) 3,927 (46.8)
Commercial 14.7 3,346 2,238 (15.5) 1,108 (13.2)
Cash 9.6 2,181 1,386 (9.6) 795 (9.5)
Discount card/ Voucher 15.3 3,498 2,131 (14.7) 1,367 (16.3)
Other 9.7 2,226 1,517 (10.5) 709 (8.5)
Emergency Department Prescriber County Urban-Rural Status
Metropolitan 88.6 20,237 12,666 (87.6) 7,571 (90.2)
Rural Adjacent 8 1,823 1,241 (8.6) 582 (6.9)
Rural Remote 3.4 786 549 (3.8) 237 (2.8)
2018 county OD rate quartile
Lowest 8.1 1,854 1,192 (8.3) 662 (7.9)
2 12.6 2,877 1,987 (13.8) 890 (10.6)
3 22 5,014 3,421 (23.7) 1,593 (19.0)
Highest 57.3 13,101 7,856 (54.3) 5,245 (62.5)